Mol Metab. 2016 Jan 25;5(4):296-304. doi: 10.1016/j.molmet.2016.01.006. eCollection 2016 Apr.
Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass.
Molecular metabolism
Pernille Barkholt, Philip J Pedersen, Anders Hay-Schmidt, Jacob Jelsing, Henrik H Hansen, Niels Vrang
Affiliations
Affiliations
- Gubra, Agern Alle 1, 2970 Hørsholm, Denmark; Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N, Denmark. Electronic address: [email protected].
- Gubra, Agern Alle 1, 2970 Hørsholm, Denmark.
- Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen N, Denmark.
PMID: 27069869
PMCID: PMC4811984 DOI: 10.1016/j.molmet.2016.01.006
Abstract
OBJECTIVE: The role of the central nervous system in mediating metabolic effects of Roux-en-Y gastric bypass (RYGB) surgery is poorly understood. Using a rat model of RYGB, we aimed to identify changes in gene expression of key hypothalamic neuropeptides known to be involved in the regulation of energy balance.
METHODS: Lean male Sprague-Dawley rats underwent either RYGB or sham surgery. Body weight and food intake were monitored bi-weekly for 60 days post-surgery. In situ hybridization mRNA analysis of hypothalamic AgRP, NPY, CART, POMC and MCH was applied to RYGB and sham animals and compared with ad libitum fed and food-restricted rats. Furthermore, in situ hybridization mRNA analysis of dopaminergic transmission markers (TH and DAT) was applied in the midbrain.
RESULTS: RYGB surgery significantly reduced body weight and intake of a highly palatable diet but increased chow consumption compared with sham operated controls. In the arcuate nucleus, RYGB surgery increased mRNA levels of orexigenic AgRP and NPY, whereas no change was observed in anorexigenic CART and POMC mRNA levels. A similar pattern was seen in food-restricted versus ad libitum fed rats. In contrast to a significant increase of orexigenic MCH mRNA levels in food-restricted animals, RYGB did not change MCH expression in the lateral hypothalamus. In the VTA, RYGB surgery induced a reduction in mRNA levels of TH and DAT, whereas no changes were observed in the substantia nigra relative to sham surgery.
CONCLUSION: RYGB surgery increases the mRNA levels of hunger-associated signaling markers in the rat arcuate nucleus without concomitantly increasing downstream MCH expression in the lateral hypothalamus, suggesting that RYGB surgery puts a brake on orexigenic hypothalamic output signals. In addition, down-regulation of midbrain TH and DAT expression suggests that altered dopaminergic activity also contributes to the reduced intake of palatable food in RYGB rats.
Keywords: Energy homeostasis; Hedonic; Hypothalamus; Mesolimbic pathway; Roux-en-Y gastric bypass
References
- World J Surg. 1998 Sep;22(9):925-35 - PubMed
- Int J Obes Relat Metab Disord. 2001 Dec;25 Suppl 5:S42-7 - PubMed
- Endocrinology. 2011 Jul;152(7):2552-7 - PubMed
- Neuron. 1999 Aug;23 (4):775-86 - PubMed
- Am J Physiol Endocrinol Metab. 2012 Jul 1;303(1):E122-31 - PubMed
- Neuroscience. 1996 Apr;71(3):735-45 - PubMed
- Am J Physiol. 1996 Oct;271(4 Pt 2):R848-56 - PubMed
- Int J Obes (Lond). 2012 Nov;36(11):1396-402 - PubMed
- Br J Pharmacol. 2013 Dec;170(7):1349-62 - PubMed
- Nature. 2000 Apr 6;404(6778):661-71 - PubMed
- J Comp Neurol. 1998 Dec 28;402(4):442-59 - PubMed
- Cell. 2001 Feb 23;104(4):531-43 - PubMed
- JPEN J Parenter Enteral Nutr. 2011 Mar;35(2):169-80 - PubMed
- Int J Obes (Lond). 2006 Mar;30(3):419-29 - PubMed
- Neuron. 1999 Feb;22(2):221-32 - PubMed
- PLoS One. 2011 Feb 22;6(2):e17339 - PubMed
- Neurosci Biobehav Rev. 2013 Nov;37(9 Pt A):1919-31 - PubMed
- Neurosignals. 2005;14(5):234-43 - PubMed
- Neuroscience. 1991;41(1):89-125 - PubMed
- Psychopharmacology (Berl). 1991;103(2):187-96 - PubMed
- Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R1057-66 - PubMed
- Biol Chem. 2013 Aug;394(8):921-36 - PubMed
- Ann Surg. 1998 May;227(5):637-43; discussion 643-4 - PubMed
- Science. 1998 May 29;280(5368):1378-83 - PubMed
- Neuroscience. 1995 Aug;67(3):625-30 - PubMed
- Int J Obes (Lond). 2011 May;35(5):642-51 - PubMed
- Obes Surg. 2010 Mar;20(3):369-74 - PubMed
- Eur J Pharmacol. 2014 Oct 15;741:254-63 - PubMed
- Obesity (Silver Spring). 2014 May;22(5):E13-20 - PubMed
- Acta Pharmacol Sin. 2012 Feb;33(2):194-200 - PubMed
- Neuroscience. 2008 Jun 23;154(2):641-52 - PubMed
- Ann Surg. 2007 Nov;246(5):780-5 - PubMed
- Stress. 2014 Dec;17(6):484-93 - PubMed
- N Engl J Med. 2012 Apr 26;366(17):1577-85 - PubMed
- Gastroenterology. 2011 Sep;141(3):950-8 - PubMed
- J Am Coll Surg. 2004 Dec;199(6):887-95 - PubMed
- Endocrinol Metab Clin North Am. 2008 Dec;37(4):923-42 - PubMed
- J Clin Invest. 2014 Oct;124(10):4473-88 - PubMed
- Nature. 2006 Sep 21;443(7109):289-95 - PubMed
- J Neurosci. 1999 May 15;19(10):RC5 - PubMed
- Nature. 1996 Jan 4;379(6560):69-72 - PubMed
- Arch Intern Med. 2010 Sep 27;170(17):1566-75 - PubMed
- Neuroreport. 2000 Jan 17;11(1):117-21 - PubMed
- Prog Neurobiol. 2010 Nov;92(3):442-62 - PubMed
- Ann Surg. 2009 Feb;249(2):269-76 - PubMed
- J Comp Neurol. 2005 Dec 5;493(1):72-85 - PubMed
- Endocrinology. 2002 Oct;143(10):3905-15 - PubMed
- Neuroscience. 2012 May 3;209:128-35 - PubMed
- J Neurosci. 1999 Dec 15;19(24):11040-8 - PubMed
- PLoS One. 2013 Jun 11;8(6):e65696 - PubMed
- N Engl J Med. 2012 Apr 26;366(17):1567-76 - PubMed
Publication Types